CM Wealth Advisors’s Immunogen Inc IMGN Stock Holding History

CM Wealth Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-18,934	Closed	-$80K	–	456
2023 Q1	$80K	Buy	+18,934	New	+$80.7K	0.02%	402

Other funds holding IMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CM Wealth Advisors's IMGN Position: Q2 2023 in Review

CM Wealth Advisors sold out of Immunogen Inc (IMGN) in Q2 2023, closing a stake of 18,934 shares — an estimated $80K sold.

CM Wealth Advisors first reported a position in IMGN in Q1 2023 and held it in 1 quarter. The position peaked at $80K in Q1 2023. 266 funds tracked by Wall St. Rank hold IMGN as of Q2 2023.

CM Wealth Advisors reported no remaining Immunogen Inc position as of Q2 2023 after selling out during the quarter.
CM Wealth Advisors sold 18,934 Immunogen Inc shares in Q2 2023, an estimated $80K.
CM Wealth Advisors first reported a position in Immunogen Inc in Q1 2023 and held it in 1 quarter.
CM Wealth Advisors's Immunogen Inc position peaked at $80K in Q1 2023.
266 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2023.

Based on CM Wealth Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.